Frequently asked questions about the prostate, EAP and its treatments

Prostate embolization is a non-surgical medical procedure used to treat benign prostatic hyperplasia (BPH). It involves the insertion of a catheter through the femoral artery, guided to the prostatic artery, where microbeads are injected to obstruct the blood vessels supplying the prostate. This reduces blood flow to the gland, reducing its size and relieving BPH symptoms such as difficulty in urinating. Prostate embolization is considered less invasive than traditional surgical treatments, with shorter recovery times and fewer side effects.

EAP is a non-surgical procedure used to treat benign prostatic hyperplasia. Its benefits include faster recovery than traditional surgery, reduced urinary symptoms, reduced risk of bleeding and incontinence, and shorter hospital stay. This less invasive technique minimizes the complications associated with surgery, while offering effective results in relieving prostate-related urinary disorders. Prostate embolization may be an attractive alternative for patients seeking effective treatment with less impact on their quality of life.

Potential risks associated with prostate embolization include, in rare cases, infection, urinary retention (1 in 500 patients) due to inflammation of the prostate, or allergic reactions to embolization agents. Although results are generally positive, side effects such as temporary pelvic pain can occur.

The choice between PAE and surgery depends on a number of individual factors, such as the size of the prostate, the patient's overall health and personal preferences. Prostate embolization, which is less invasive, can offer a faster recovery with fewer side effects, and in no way affects sexual function. More traditional surgery may be recommended by your urologist, bearing in mind that it is highly invasive and can lead to retrograde ejaculation and harm your sexual health. Studies now show that both techniques have the same success rate, but one is less invasive than the other.

These are two distinct approaches to two distinct pathologies. While embolization aims to reduce the size of the prostate and alleviate the symptoms of Benign Prostatic Hyperplasia, radiotherapy specifically targets prostate cancer cells. The choice between the two depends on the underlying condition, BPH or cancer, and requires careful assessment of individual risks, benefits and preferences.

EAP and prostate surgery are two distinct approaches to treating the symptoms of prostatic hypertrophy. Embolization involves blocking the blood vessels supplying the prostate, thereby reducing its volume. This method is less invasive than surgery and can be performed under local anaesthetic. In contrast, prostate surgery or TURP, such as prostatectomy, involves partial or total surgical removal of the prostate. Although more invasive, surgery may be necessary in certain severe cases. The choice between the two depends on the nature of the problem and the patient's preferences.

EAP treats BPH, while focal cryotherapy treats prostate cancer.

Prostate embolization is generally well tolerated, with minimal pain. This non-surgical procedure aims to treat benign prostatic hyperplasia by reducing blood flow to the prostate gland. Patients may experience mild discomfort or a sensation of warmth during the procedure, which is performed under local anaesthetic. After embolization, some individuals report minor pain or a feeling of pressure, but these side effects are usually temporary and well controlled by painkillers. Compared with other treatment options, prostate embolization is often considered less painful, and offers potential advantages in terms of recovery.

Your urologist may not have mentioned this technique for a number of reasons. Firstly, embolization is an emerging technique and may not be widely known or practiced by all urologists. In addition, the choice of treatment often depends on the complexity of each case and the patient's individual preferences.

EAP is a promising option for treating symptoms associated with benign prostatic hyperplasia (BPH). This minimally invasive procedure uses particles to block the blood vessels supplying the prostate, thereby reducing its size. Unlike other more invasive treatments, embolization offers advantages such as shorter recovery times, reduced risk of sexual complications, and can be considered in patients who are not candidates for other procedures. If embolization has not been discussed, it may be beneficial to discuss this option with your urologist to assess whether it is suitable for your particular situation.

The appropriateness of this procedure in young men depends on the severity of symptoms and individual medical assessment. Young men with significant symptoms of prostatic hyperplasia may consider embolization as an alternative to more invasive treatments. It is crucial to consult a healthcare professional to determine the best treatment option based on the patient's overall health and specific needs.

Prostate embolization is recommended for all patients with benign prostatic hyperplasia. It is generally considered for men with benign prostatic hyperplasia (BPH) and severe symptoms such as urinary disorders.

Alternatives to prostatic embolization to treat benign prostatic hypertrophy include transurethral resection of the prostate (TURP), laser vaporization, open surgery, medications such as alpha-blockers and 5-alpha reductase inhibitors. TURP is a common procedure involving the transurethral removal of excess prostate tissue. Laser vaporization uses a laser to destroy prostate tissue. Medication works by reducing symptoms. It's important to note that embolization remains the only technique that completely preserves your sexuality.

Side effects may include temporary pelvic pain, transient urinary disorders, blood in the urine or semen, and allergic reactions to the imaging agents used. Rarer complications include infection or vascular problems. However, most side effects are temporary and disappear fairly quickly.

Prostate embolization should be considered as a treatment option for men with benign prostatic hyperplasia (BPH) presenting moderate to severe symptoms, particularly if they do not respond to drug treatments or prefer to avoid surgery. This non-invasive procedure uses particles to obstruct the arteries feeding the prostate, thereby reducing the size of the gland and improving urinary symptoms. It can be an effective alternative to traditional surgery, offering benefits such as faster recovery and fewer side effects.

Insurance coverage for EAP depends on each individual's specific contract. Some health insurance plans may include the procedure as an integral part of coverage, while others may consider it an optional medical intervention, entailing additional costs. It is essential to check the details of the insurance policy, contact the insurance company and, if necessary, request prior authorization to determine specific coverage. Information concerning medical coverage may vary, and it is advisable to contact the insurer directly for precise information.

Yes, prostate hypertrophy can be visualized by ultrasound, offering a non-invasive and accurate means of monitoring the progress of the pathology.

Recovery time may vary from one individual to another, but generally patients can return to their normal activities within a few days. Symptoms such as pelvic pain, urinary disorders and bleeding may gradually diminish over the weeks following the procedure. It is essential to follow the doctor's advice regarding rest, physical activity and prescribed medication to optimize recovery. Regular follow-ups with the healthcare professional are also recommended to assess progress and resolve any potential problems.

This alternative method to traditional surgery often offers a faster recovery and fewer side effects. Patients generally report an improvement in urinary symptoms, such as frequency and difficulty in urinating. By reducing pressure on the urethra, quality of life is significantly improved by relieving the urinary disorders associated with prostatic hyperplasia, while minimizing the risks associated with surgery.

Studies show promising long-term results. They suggest a significant improvement in urinary symptoms and a reduction in prostate size. Benefits include a reduced risk of bleeding and complications compared with other procedures. Patients report improved quality of life and erectile function. However, long-term research is needed to confirm the long-term efficacy and safety of this emerging procedure. Regular medical follow-up is recommended to assess the persistence of benefits.

Yes, prostate embolization can be repeated if necessary. Although this procedure is generally effective in treating the symptoms of benign prostatic hyperplasia (BPH), situations such as further prostate growth or a return of symptoms may necessitate repeat embolization. The decision to repeat the procedure will depend on the patient's clinical assessment by his or her physician, taking into account factors such as prostate size and severity of symptoms.